Newsfiscal.ai
Psyence Biomedical Completes Investment in PsyLabs Following Milestone Achievement
· Published
Article summary
Psyence Biomedical Ltd. has finalized a $2,599,896 investment in Psyence Labs Ltd. after achieving key regulatory and manufacturing milestones for its ibogaine program.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…